<DOC>
	<DOCNO>NCT02428894</DOCNO>
	<brief_summary>The purpose study characterize change plasma proteome time follow leave ventricular assist device ( LVAD ) implantation .</brief_summary>
	<brief_title>Characterization Plasma Proteome Following Left Ventricular Assist Device Implantation</brief_title>
	<detailed_description />
	<mesh_term>Ventricular Dysfunction</mesh_term>
	<mesh_term>Ventricular Dysfunction , Left</mesh_term>
	<criteria>Planned HeartMate II LVAD implantation Planned warfarin ( goal INR , 2.03.0 ) lowdose aspirin therapy postLVAD placement Prior history mechanical circulatory support ; Body weight &lt; 110 lb ; Preexisting hemolytic , bleeding , immunologic disorder prior LVAD implantation ; Severe aortic stenosis ; Renal failure require dialysis ; Hepatic dysfunction result severe coagulopathies ; Recent serious infection ; Current need prolonged ventilatory support ; Prior organ transplantation ; Blood transfusion within 14 day first plan study blood draw ; Concomitant immunosuppressant chemotherapeutic agent ; Pregnant woman ; Decisionally challenge prisoner ; Unwilling provide write informed consent</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>